Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX r&d expenses
Research and development expenses are spending on new products and technology.
Zeo ScientifiX's R&D Expenses for the twelve months ending Oct 31, 2022 was $791.30K. For fiscal 2025 it was $100.00K, down 39.0% from the year before. The highest annual figure on record is $1.12M in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $100.00K | -39.0% |
| FY2024 | Oct 31, 2024 | $164.00K | -82.2% |
| FY2023 | Oct 31, 2023 | $922.70K | +16.6% |
| FY2022 | Oct 31, 2022 | $791.30K | -29.4% |
| FY2021 | Oct 31, 2021 | $1.12M | +379.6% |
| FY2020 | Oct 31, 2020 | $233.53K | +325.7% |
| FY2019 | Oct 31, 2019 | $54.86K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $31.00K | +520.0% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $19.00K | -29.6% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $42.00K | -87.5% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $6.00K | -95.3% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $5.00K | -95.5% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $27.00K | -90.2% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $335.00K | +21.2% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $126.80K | -45.6% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $111.60K | +14.2% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $276.60K | +822.0% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $276.30K | +722.3% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $233.00K | +223.6% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $97.73K | – |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $30.00K | – |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $33.60K | – |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $72.00K | – |
See a number that looks wrong?